Indamax

Quick links to important sections

Indamax

Treatment option: Hypertension

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Indamax

What is Indamax? (Indapamide)

Property Description
Active ingredient Indapamide
Form Film-coated tablets
Pharmacological class Thiazide-like diuretic, Antihypertensive agent
General purpose Management of high blood pressure (Essential hypertension)
Origin Synthetic compound (Sulfonamide derivative)

What Type of Medicine is Indamax?

Indamax is a prescription-only medicine containing the active substance Indapamide. It is classified as an antihypertensive agent and a thiazide-like diuretic. The medicine is a synthetic compound derived from the chemical group of sulfonamide derivatives, manufactured for oral administration in the form of film-coated tablets. Indapamide's unique structure differs from classic thiazides, providing a balanced and potent effect on the circulatory system. This differentiation is clinically recognized for its long-acting profile, suitable for chronic cardiovascular management in adult patients.


Indapamide's Classification and General Purpose

Indapamide's general therapeutic purpose is to effectively assist in the management of elevated blood pressure, specifically essential hypertension. The medicine achieves this through two primary, complementary actions: enhancing the body's natural removal of excess sodium and water (diuresis), and concurrently causing the peripheral blood vessels to relax and widen. This contribution of reducing fluid volume and lowering vascular resistance lessens the overall pressure burden on the cardiovascular system. This combined mechanism provides support for controlling hypertension. The result is a controlled, reduced blood pressure level, which is the foundational benefit this single-ingredient product provides.

Regulatory References

  1. Indapamide/Perindopril Public Assessment Report (e.g., Flutensif)

What side effects are possible with Indamax?

Possible Side Effects and Safety Information

The safety profile for Indamax (Indapamide) is defined by officially documented adverse reactions that are primarily related to its effect on fluid and electrolyte balance. The most common adverse reactions listed in regulatory documents involve Metabolism and Nutrition Disorders, specifically Hypokalaemia (low potassium) and Hyponatraemia (low sodium), which necessitate mandated laboratory monitoring throughout therapy.


Safety Classifications and Associated Risks

Adverse reactions are classified by frequency as follows:

Classification Examples of Documented Effects
Common (1/100 to 1/10) Headache, Dizziness, Fatigue, Rash, Hypokalaemia
Uncommon (1/1,000 to 1/100) Vomiting, Orthostatic hypotension
Rare (1/10,000 to 1/1,000) Gout (due to Hyperuricaemia), Vertigo

Serious and Population-Specific Safety Notes

The official label documents rare but serious risks, including the potential for life-threatening heart rhythm disturbances such as Torsades de pointes, and the ocular risk of Acute Angle-Closure Glaucoma. As a sulfonamide derivative, it carries a class-related risk for severe dermatological reactions.

Specific populations require explicit consideration: Older adults are noted to have an increased susceptibility to severe Hyponatraemia. Individuals with pre-existing Hepatic Impairment or Severe Renal Impairment require heightened safety observation, as minor electrolyte changes can precipitate conditions like Hepatic Encephalopathy or Azotemia. Some effects, such as Azotemia, are officially stated to be more likely at the start of treatment or following a dose adjustment.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Indapamide overdose emphasizes that any suspected ingestion requires immediate medical attention. Overdose symptoms are primarily an exaggeration of the diuretic's effects, leading to severe disturbances in fluid and electrolyte balance.


Documented Manifestations and Severe Outcomes

Classification Official Regulatory Statement
Documented Signs Overdose may present with marked hypotension, nausea, vomiting, dizziness, sleepiness, mental confusion, and severe fluid loss indicated by dry mouth and thirst (Source: FDA/EMA Labeling).
Severe Outcomes Consequences include severe arrhythmias (e.g., Torsades de pointes) induced by hypokalemia, respiratory depression, and potential progression to anuria or hepatic encephalopathy in susceptible patients (Source: FDA/EMA Labeling).

Emergency Actions and Required Monitoring

Regulators mandate that immediate medical attention be sought. The primary management is strictly symptomatic and supportive, as no specific antidote is known. Officially described procedures include gastric lavage or administration of activated charcoal to limit absorption. Treatment requires close hospital monitoring to ensure the urgent restoration of fluid and electrolyte balance. Increased monitoring of plasma sodium and potassium is essential for the elderly and cirrhotic patients due to their heightened susceptibility to severe imbalances, as defined in regulatory documents.

Therapeutic Uses of Indamax

What Indamax Treats: Main Uses and Benefits

Indamax is commonly used in treatment regimens for essential hypertension (high blood pressure) in adults. The medicine is primarily used to address the symptomatic cluster of elevated systolic and diastolic readings, which are the objective markers of circulatory pressure overload. Indapamide is also used to manage hypertension and fluid retention associated with heart failure.

This therapy helps address groups of symptoms that may intensify over time, providing support that contributes to easing the overall symptom load. A key therapeutic focus involves cardiovascular protection; this medicine is considered relevant for managing objective risk factors that drive future major symptomatic episodes, such as stroke and myocardial infarction (heart attack). Indapamide is relevant in conditions involving systemic imbalance, specifically addressing edema (swelling) due to excess fluid and salt retention.

“The sustained control achieved through therapy assists with maintaining blood pressure within a target range and supports general well-being during symptomatic phases.”

This strategy may help patients cope more steadily with symptom fluctuations and is applied in clinical settings that involve acute or unstable symptom patterns. This application may assist with maintaining functional stability and supports general comfort by easing the overall symptom burden.


Quick Fact: Relevant for Managing Fluid Volume Overload

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Eligibility Scope

Category Official Regulatory Statement
Populations for whom use is allowed Adult patients (18 years and over) who do not have documented contraindications [EMA SmPC, FDA Label].
Populations for whom use is not recommended Children and adolescents (under 18 years), as regulatory safety and efficacy data have not been established [EMA SmPC]. Pregnant and breastfeeding individuals [FDA Label].
Populations for whom use is contraindicated Patients with known hypersensitivity to indapamide or sulfonamide derivatives [EMA SmPC]. Patients with severe renal failure (creatinine clearance < 30 mL/min), hepatic encephalopathy, severe hepatic impairment, or hypokalaemia [EMA SmPC].

Eligibility Classifications (High-Level)

Classification Official Regulatory Wording
Age-related eligibility rules Adults are the approved population. Paediatric use is not recommended. Older adults require consideration of renal function [EMA SmPC].
Condition-specific eligibility rules Contraindicated in severe organ dysfunction (renal/hepatic) and hypokalaemia. Conditional use in mild-to-moderate impairment and pre-existing electrolyte imbalance [EMA SmPC].

Official Eligibility Statements:

  • Contraindicated for individuals with hypersensitivity to indapamide or any sulfonamide derivative.
  • The medicine must not be used in severe renal failure, hepatic encephalopathy, or severe hepatic impairment.
  • It is contraindicated in patients with pre-existing hypokalaemia.
  • Use is not recommended in children and adolescents under 18 years of age.

Regulatory documents strictly define who can and cannot use Indamax primarily through absolute contraindications linked to chemical class sensitivity, severe organ failure, and critical metabolic conditions. Eligibility is strictly established for the adult population, while use is formally not recommended for paediatric patients, pregnant, and breastfeeding individuals.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Indapamide, the active substance in Indamax, has officially documented interaction patterns based primarily on its impact on electrolyte balance and blood pressure regulation. This section describes specific documented constraints and co-administration risks, as defined by government regulatory sources.


Documented Interaction Patterns

Interacting Substance/Class Officially Documented Outcome Classification
Lithium Reduced renal clearance, leading to high risk of toxicity. Pharmacokinetic/Exposure-Modifying
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Loss of antihypertensive effect and increased risk of renal impairment. Pharmacodynamic
Agents that prolong the QTc interval Increased risk of QTc prolongation (additive effect). Pharmacodynamic
Corticosteroids or ACTH Increased risk of hypokalemia (low potassium levels). Pharmacodynamic

Specific Constraints and Considerations

The co-administration of Indapamide with Amifostine at chemotherapeutic doses requires a mandatory timing rule: Indamax must be withheld for 24 hours prior to Amifostine administration. Alcohol (ethanol) may also have additive effects in lowering blood pressure, which may increase the risk of hypotension.

Interaction severity can be heightened in specific populations. Regulatory documents note an increased risk of severe hyponatremia and hypokalemia in geriatric patients. Furthermore, minor fluid and electrolyte alterations in patients with impaired hepatic function may precipitate hepatic coma.

Mechanism of Action

The action of Indamax involves a dual mechanism that targets both the kidney's fluid-regulating systems and the intrinsic mechanics of the vascular system. This complementary action contributes to a modification of cardiovascular load through two separate pathways.

Inhibition of Renal Salt and Water Reabsorption

This domain describes the mechanism's action on fluid homeostasis by targeting the Sodium-Chloride Cotransporter (NCC) in the kidney. By inhibiting this transporter, the molecule reduces the kidney's ability to reclaim Na^+ and Cl^- ions, leading to an increase in the urinary excretion of water and salt (diuresis). This molecular interference ultimately results in a change in the overall fluid volume circulating in the bloodstream.

Direct Modulation of Vascular Smooth Muscle Tone

The second mechanism involves a direct action on the peripheral blood vessels, where the molecule modulates the influx of calcium ions across the membranes of vascular smooth muscle cells. Since calcium is required for muscle contraction, limiting its availability causes the arteries to relax and widen (vasodilation). This mechanism leads to a decrease in the resistance against blood flow (Total Peripheral Resistance), which is a component of the molecule's physiological profile independent of volume reduction.

Dosage and Administration Information

How to Use Indamax

Indamax (Indapamide) is administered exclusively via the oral route as a film-coated tablet for long-term, continuous management of hypertension and edema. The official guidelines detail the standardized approach to its administration, including specific dosing, frequency, and conditions for use.


Official Dosing and Frequency

Indamax is a once-daily medication, typically taken in the morning to prevent interference with sleep from increased urination. The standard adult dosing regimens are structured by indication:

Indication Initial Daily Dose Maximum Daily Dose
Hypertension 1.25 mg 5 mg
Edema (Fluid Retention) 2.5 mg 5 mg

For managing high blood pressure, any dose increase is officially recommended to occur only after a minimum period of four weeks to allow for a complete assessment of the blood pressure response to the current dosage.


Administration Requirements

The tablet may be ingested with or without food, as the presence of a meal does not affect the drug's bioavailability. The film-coated tablets, including prolonged-release forms, must be swallowed whole and should not be crushed, split, or chewed, which is a required step for proper administration.

Population-Specific Use

Official prescribing information for Indamax indicates that the safety and effectiveness of the medicine have not been established for use in pediatric patients (under 18 years of age). For older adults, treatment is typically initiated at the lower end of the dosing range due to the potential for reduced organ function. Furthermore, the use of Indapamide is constrained in patients with severe renal or hepatic impairment, reflecting the drug's reliance on functioning organs for its effect.

Recent Clinical Evidence

Research evidence / Overview of Studies for Indamax

Evidence for Use in Essential Hypertension

This section will summarize the types of randomized controlled trials (RCTs) and meta-analyses that have examined the effect of the medicine on short-term and intermediate changes in blood pressure readings, as well as on structural markers related to cardiovascular strain.

Research has focused on the evaluation of Indapamide in conditions characterized by elevated blood pressure, known as essential hypertension. Studies conducted often involve Randomized Controlled Trials (RCTs) where patients was observed in a structured setting over defined time intervals. These trials primarily research examined outcomes related to systemic or functional imbalance, specifically the change in the two key measures of circulatory pressure: Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP). Findings describe patterns observed in the studies related to blood pressure measurements, and research highlights changes measured during the study period. Other studies explored outcomes monitoring physiological strain or stress, such as measuring changes in the Left Ventricular Mass Index (LVMI).

However, there is limited information for long-term outcomes regarding major cardiovascular events when Indapamide was studied for hypertension as a single agent (monotherapy). Data for certain groups remain insufficient for drawing broad conclusions, and results apply only to the populations studied under the specific conditions of the trials.


Evidence for Reducing Major Cardiovascular Risk

This part will outline the large-scale, long-term outcome studies and systematic reviews that have investigated the occurrence of major clinical events, such as fatal and non-fatal stroke or heart attack, in high-risk adult populations.

Studies involving Indapamide was studied for the purpose of evaluating measurements related to major health events like stroke and heart attack. These were typically large-scale, long-term RCTs, often lasting several years, designed to monitor patients with high cardiovascular risk. The trials research examined hard clinical outcomes, including fatal and non-fatal stroke, myocardial infarction (heart attack), and overall mortality rates. Findings indicate that these major outcomes was observed in patients who typically received Indapamide as a component of a combination regimen, often alongside another antihypertensive agent. Isolating the full preventative effect solely to Indapamide remains uncertain because the data is significantly driven by studies using the medicine in combination.


What is Still Uncertain About Indamax Research

Although a substantial body of evidence exists, the research landscape does have limitations. A primary limitation is that the most robust data on reducing major cardiovascular events comes from trials where Indapamide was observed in combination with other agents. This means that comparative evidence is lacking when trying to isolate the long-term effect of Indapamide when used as a single medication. Furthermore, while short-term and intermediate-term blood pressure measurements was studied for extensively, there is limited information for long-term outcomes that extend beyond the defined follow-up durations of the clinical trials.

Key Studies & References

  1. National Institute for Health and Care Excellence (NICE) Guideline NG136: Hypertension in adults: diagnosis and management.

Frequently Asked Questions (FAQ)

Common questions about Indamax (FAQ)

Q: How is Indamax different from other treatments for the same condition?

According to the official product information, Indamax is classified as a thiazide-like diuretic. Its unique chemical structure gives it a dual action, working both on fluid removal and on blood vessel relaxation. This combined effect distinguishes it from classic diuretics and supports its use for the long-term management of high blood pressure.

Q: Does Indamax start working right away?

The initial effects of fluid removal (diuresis) may begin within a few hours of administration. However, the regulatory information indicates that the complete blood pressure-lowering effect typically requires consistent daily use for one to two weeks to be clinically assessed.

Q: What should I do if I think Indamax is making me tired?

Fatigue and weakness are documented as possible effects in official safety documents. The documentation notes that such effects, or any other adverse effect, require the oversight of a healthcare professional.

Q: Are there any common foods or drinks that interact with Indamax?

Regulatory documents state that the medicine can be taken with or without food, as food does not significantly affect its absorption. Official warnings, however, describe constraints on alcohol consumption, as it may modify the blood pressure lowering effect.

Q: What is the list of ingredients in Indamax?

Indamax contains the active ingredient Indapamide. It also contains several inactive ingredients (excipients), which are required to form the tablet. Official labeling notes that these ingredients typically include compounds like lactose and cellulose, and the formulation is described as sodium-free in regulatory documents.

Q: Does Indamax need any special testing before starting it?

Official prescribing information indicates the necessity of periodic laboratory monitoring to be performed during treatment. This monitoring typically involves testing blood levels of serum electrolytes (like sodium and potassium) and assessing renal (kidney) function.

Q: Has Indamax been approved in countries outside of the US?

Regulatory information citing the European Medicines Agency (EMA) and UK governing bodies indicates the medicine is approved and regulated as a prescription-only medicine in European and other international territories.

Q: Why is Indamax only available by prescription?

The medicine is classified as Prescription Only (Rx) because its safe and effective use requires professional diagnosis and supervision. This oversight is necessary due to the potential for side effects, such as electrolyte imbalance, which is associated with mandated monitoring by a healthcare professional.

Q: How long do people typically stay on Indamax treatment?

The medicine is officially designed for long-term, continuous management of the condition. Clinical studies indicate that the maximum blood pressure-reducing effect is typically maintained after being reached at approximately three to four months of regular treatment.

Q: Is the research evidence for Indamax considered strong?

Research shows the medicine is an effective agent for reducing elevated blood pressure and is classified by authorities as a long-term treatment option. Studies have observed a reduction in major cardiovascular risks when Indamax is used as part of a combination regimen.

Q: Can Indamax be used in patients with a history of heart issues?

It is indicated for treating fluid retention (edema) associated with congestive heart failure. However, its use is associated with a need for caution and monitoring, as it carries a specific, rare risk for heart rhythm disturbances (Torsades de pointes) linked to electrolyte imbalance.

Q: Is Indamax a new kind of medicine?

The medicine belongs to the indoline class of antihypertensive/diuretics. Regulatory documents note that the medicine was approved for use by the FDA in 1983.

Q: What happens if I forget to take Indamax?

Regulatory guidance for a missed dose describes taking it as soon as it is remembered, unless it is close to the next scheduled time. The guidance also explicitly states that a double or extra dose should not be taken.

Q: Are the side effects of Indamax temporary?

Side effects are classified by frequency (common, uncommon, rare) in official documents, but they are not universally temporary. If an adverse effect occurs, official documentation indicates it can potentially persist and may require further medical management.

Q: Can Indamax cause long-term health issues?

Long-term use is associated with a need for ongoing monitoring of serum electrolytes and uric acid levels. Official safety information notes that prolonged use may precipitate hyperuricemia (which can lead to gout) or exacerbate renal impairment in some patients.

Q: Is it normal to feel a bit nauseous when first starting Indamax?

Nausea is listed in regulatory safety documents as an uncommon or rare side effect. It is not classified as one of the most frequently reported adverse reactions.

Q: Can Indamax affect birth control pills?

Official information does not specify a known drug-specific interaction with oral contraceptive pills. However, severe gastrointestinal side effects like vomiting or severe diarrhea may functionally reduce the effectiveness of the birth control pill.

Q: Is Indamax a controlled substance?

The medicine is explicitly classified by regulatory bodies as Not a controlled medication.

Q: Does taking Indamax affect driving ability?

The official label notes that the decrease in blood pressure may cause individual reactions like dizziness or lightheadedness, especially at the start of treatment. These effects may temporarily impair the ability to drive vehicles or operate machinery.

Q: Will I have withdrawal symptoms if I stop taking Indamax?

Clinical observations cited in official documents have not identified a withdrawal syndrome at the time of discontinuation of therapy.

Q: Is there a generic version of Indamax available?

Regulatory information indicates that the original brand name formulation has been discontinued. The medicine is currently available as generic versions.

Q: Can Indamax be taken with supplements or vitamins?

The official patient information emphasizes the necessity of disclosing all current medicines and products, including supplements and vitamins. This is due to the potential for interactions that may affect the body's salt balance and drug effectiveness.

Q: Is Indamax described as habit-forming in official documents?

Regulatory documents do not classify the medicine as a controlled substance. Furthermore, clinical studies have not reported a withdrawal syndrome upon discontinuation of therapy, which addresses the concept of habit-forming potential.

Q: What if I accidentally take two doses of Indamax close together?

Accidental double doses can increase the risk of symptoms like dizziness, low blood pressure, or increased side effects. Official guidance states that symptoms following an accidental double dose may require immediate medical advice.

How should Indamax be stored and disposed of?

How to Store and Dispose of Indamax?

Indamax tablets must be stored according to official regulatory guidelines to maintain their stability and effectiveness.

Official Storage Requirements

Condition Regulatory Rule
Temperature Store at room temperature, typically between 20 C to 25 C (68 F to 77 F), and keep from freezing.
Environment Protect from excess heat and moisture. Do not store the medicine in a bathroom cabinet.
Packaging Keep the tablets in the original container and blister pack, ensuring the container remains tightly closed.

Handling and Disposal

The medicine must be kept out of the sight and reach of children and secured with safety caps. Do not use Indamax after the expiry date printed on the packaging or if the tablets appear broken or discolored. Outdated or unused Indamax must not be kept; official disposal guidance requires consulting a healthcare professional or local authority for the proper method of discarding the product.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Indamax found in:

A-Z Index: